3-42865451-C-T
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_001296.5(ACKR2):c.949C>T(p.His317Tyr) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000144 in 1,614,218 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_001296.5 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
ACKR2 | NM_001296.5 | c.949C>T | p.His317Tyr | missense_variant | 3/3 | ENST00000422265.6 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
ACKR2 | ENST00000422265.6 | c.949C>T | p.His317Tyr | missense_variant | 3/3 | 1 | NM_001296.5 | P1 |
Frequencies
GnomAD3 genomes AF: 0.000210 AC: 32AN: 152224Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.000219 AC: 55AN: 251012Hom.: 0 AF XY: 0.000206 AC XY: 28AN XY: 135640
GnomAD4 exome AF: 0.000137 AC: 201AN: 1461876Hom.: 0 Cov.: 30 AF XY: 0.000144 AC XY: 105AN XY: 727238
GnomAD4 genome AF: 0.000210 AC: 32AN: 152342Hom.: 0 Cov.: 32 AF XY: 0.000175 AC XY: 13AN XY: 74482
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Dec 21, 2023 | The c.949C>T (p.H317Y) alteration is located in exon 3 (coding exon 1) of the ACKR4 gene. This alteration results from a C to T substitution at nucleotide position 949, causing the histidine (H) at amino acid position 317 to be replaced by a tyrosine (Y). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at